Amicus Therapeutics, Inc. (FOLD) Stock Analysis

Free AI-powered analysis and research for Amicus Therapeutics, Inc. stock

Sector: Healthcare

Full FOLD report

Amicus Therapeutics, Inc. (FOLD) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze FOLD Now →

📰 Latest Update

BioMarin Completes Acquisition of Amicus Therapeutics

Mon, April 27, 2026 at 12:44 PM UTC 2 min read

BioMarin Pharmaceutical has successfully completed its acquisition of Amicus Therapeutics, a move aimed at enhancing its portfolio in rare disease treatments. This acquisition is significant for investors as it positions BioMarin to expand its market presence and leverage Amicus's innovative therapies, potentially driving future revenue growth. The integration of Amicus's assets could also strengthen BioMarin's pipeline, making it a more competitive player in the biopharmaceutical sector.

Read full article →

People also watch

ISRG

Intuitive Surgical Inc.

REGN

Regeneron Pharmaceuticals Inc.

MRK

Merck & Co. Inc.

QSI

Quantum-Si incorporated

EVH

Evolent Health, Inc.